Zenith Drugs (NSE:ZENITHDRUG) Total Debt per Share: ₹32.13 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ZENITHDRUG Zenith Drugs Ltd NSE:ZENITHDRUG
38 GF Score
Price ₹43.15
! 6 Warning Signs
View Full Analysis

What is Zenith Drugs Total Debt per Share?

Zenith Drugs NSE:ZENITHDRUG -6.40% 38 Total Debt per Share is ₹32.13 as of Mar. 2026. GuruFocus rates NSE:ZENITHDRUG with a GF Score™ of 38/100. The stock has 6 warning signs investors should review.

₹32.13 (As of Mar. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Zenith Drugs's Total Debt Per Share for the quarter that ended in Mar. 2026 was ₹32.13.

Zenith Drugs Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Zenith Drugs's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Drugs Total Debt per Share Chart

Zenith Drugs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Debt per Share
Get a 7-Day Free Trial 15.67 21.71 13.96 28.32 32.13

Zenith Drugs Semi-Annual Data
Mar24 Sep24 Mar25 Sep25 Mar26
Total Debt per Share 13.96 23.06 28.32 30.26 32.13
NSE:ZENITHDRUG
38GF Score
Zenith Drugs Ltd NSE:ZENITHDRUG
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenith Drugs Total Debt per Share Calculation

Zenith Drugs's Total Debt Per Share for the fiscal year that ended in Mar. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(201+350)/17
=32.13

Zenith Drugs's Total Debt Per Share for the quarter that ended in Mar. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(201+350)/17
=32.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of ₹32.13 mean?
Zenith Drugs (NSE:ZENITHDRUG) has a Total Debt per Share of ₹32.13 as of Mar. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Zenith Drugs and its competitors.
Is Zenith Drugs' Total Debt per Share too high?
Zenith Drugs' current Total Debt per Share is ₹32.13. Overall, Zenith Drugs has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Zenith Drugs' Total Debt per Share compare to ZTS?
Zenith Drugs' Total Debt per Share of ₹32.13 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Drug Manufacturers company?
A good Total Debt per Share depends on the Drug Manufacturers industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Zenith Drugs and its competitors. Zenith Drugs's current Total Debt per Share is ₹32.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Drugs stock overvalued right now?
Zenith Drugs (NSE:ZENITHDRUG) has a current Total Debt per Share of ₹32.13. The current Total Debt per Share is ₹32.13. Zenith Drugs' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Zenith Drugs (NSE:ZENITHDRUG), the current Total Debt per Share is ₹32.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zenith Drugs Business Description

Address K. No. 72/5, Village Muradpura, Depalpur, Indore, MP, IND, 453001
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, Creams, Gels, Capsules, and Tablets. It is also into Generic Medicines.
38GF Score

Get the complete analysis for NSE:ZENITHDRUG

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹43.15
Price